MEP1A allele for meprin A metalloprotease is a susceptibility gene for inflammatory bowel disease

S Banerjee1, B Oneda, L M Yap

  • 1Department of Biochemistry & Molecular Biology, The Pennsylvania State University College of Medicine, Hershey, Pennsylvania, USA.

Mucosal Immunology
|March 6, 2009
PubMed

Insights

The MEP1A gene is linked to ulcerative colitis (UC), a type of inflammatory bowel disease (IBD). Reduced meprin-alpha expression in the gut is associated with IBD severity in patients and mouse models.

Area of Science:

  • Genetics
  • Gastroenterology
  • Immunology

Background:

  • The MEP1A gene, encoding meprin-alpha, is located in a region associated with inflammatory bowel disease (IBD).
  • Meprin-alpha is expressed in the intestinal epithelium, suggesting a role in gut health.

Purpose of the Study:

  • To investigate the association of the MEP1A gene with ulcerative colitis (UC), a major form of IBD.
  • To examine the role of meprin-alpha expression in intestinal inflammation.

Main Methods:

  • Genetic association study of single-nucleotide polymorphisms (SNPs) in the MEP1A gene in a cohort of UC patients.
  • Quantitative analysis of meprin-alpha mRNA levels in inflamed intestinal mucosa.
  • Evaluation of intestinal injury and inflammation in meprin-alpha knockout mice using a dextran sulfate sodium (DSS) model.

Main Results:

  • Significant genetic associations were found between MEP1A SNPs and UC susceptibility.
  • Meprin-alpha mRNA levels were decreased in inflamed mucosa from IBD patients.
  • Meprin-alpha knockout mice showed exacerbated intestinal injury and inflammation in the DSS model.

Conclusions:

  • The MEP1A gene is implicated as a susceptibility gene for UC.
  • Decreased meprin-alpha expression is linked to intestinal inflammation in IBD patients and experimental models.

Related Concept Videos

Inflammatory Bowel Disease III: Crohn's Disease01:25

Inflammatory Bowel Disease III: Crohn's Disease

Crohn’s disease is a chronic, relapsing form of inflammatory bowel disease characterized by segmental, transmural inflammation that can affect any part of the gastrointestinal tract. Its pathogenesis arises from a combination of genetic susceptibility, environmental exposures, epithelial barrier dysfunction, and immune dysregulation. Together, these factors lead to an exaggerated immune response against components of the gut microbiome.Genetic and Environmental InfluencesMultiple genetic...
Inflammatory Bowel Disease II: Ulcerative Colitis01:20

Inflammatory Bowel Disease II: Ulcerative Colitis

Ulcerative colitis is a chronic inflammatory disorder of the colon characterized by continuous mucosal inflammation that typically begins in the rectum and extends proximally in a uniform pattern. Its pathogenesis involves a complex interplay of genetic predisposition, immune dysregulation, and environmental influences. These factors converge to impair the colon’s epithelial defenses and promote an exaggerated inflammatory response against luminal contents.Breakdown of the Mucosal BarrierA...
Inflammatory Bowel Disease I: Ulcerative Colitis01:27

Inflammatory Bowel Disease I: Ulcerative Colitis

Introduction
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
Amebiasis01:28

Amebiasis

Entamoeba histolytica, a protozoan parasite, is responsible for intestinal and extraintestinal amebiasis. Though a significant proportion of infections remain asymptomatic, approximately 50 million individuals annually are estimated to present with clinical disease, resulting in up to 100,000 deaths globally. The disease burden is disproportionately high in regions with lower socioeconomic status, such as parts of India, Africa, Mexico, and Latin America.Etiology and TransmissionThe infective...
Inflammatory Bowel Disease I: Introduction01:26

Inflammatory Bowel Disease I: Introduction

Inflammatory bowel disease is a group of chronic disorders marked by recurrent inflammation of the gastrointestinal tract due to an abnormal immune response against gut microflora. This leads to tissue damage. The two main forms are Crohn’s disease and ulcerative colitis.Crohn’s DiseaseCrohn’s disease is a relapsing inflammatory disorder that can affect any part of the GI tract, from the mouth to the anus. It involves all layers of the bowel wall (transmural) and shows “skip lesions” in which...
Inflammatory Bowel Disease II: Crohn's Disease01:30

Inflammatory Bowel Disease II: Crohn's Disease

Introduction
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by transmural...